N-[2-(1-cyclopropyl-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(2,8-dimethylquinazolin-4-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-fluoroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[1-(8-methylindolizin-3-yl)ethyl]-1,4-oxazepane-6-carboxamide

C159H217F2N35O20 — CID 162248853

About N-[2-(1-cyclopropyl-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(2,8-dimethylquinazolin-4-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-fluoroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[1-(8-methylindolizin-3-yl)ethyl]-1,4-oxazepane-6-carboxamide

N-[2-(1-cyclopropyl-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(2,8-dimethylquinazolin-4-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-fluoroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[1-(8-methylindolizin-3-yl)ethyl]-1,4-oxazepane-6-carboxamide (PubChem CID 162248853) has the molecular formula C159H217F2N35O20 and a molecular weight of 2976.71 g/mol. Its IUPAC name is N-[2-(1-cyclopropyl-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(2,8-dimethylquinazolin-4-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-fluoroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[1-(8-methylindolizin-3-yl)ethyl]-1,4-oxazepane-6-carboxamide.

Molecular Properties

• Compound Name: N-[2-(1-cyclopropyl-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(2,8-dimethylquinazolin-4-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-fluoroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[1-(8-methylindolizin-3-yl)ethyl]-1,4-oxazepane-6-carboxamide
• PubChem CID: 162248853
• Molecular Formula: C159H217F2N35O20
• Molecular Weight: 2976.71 g/mol
• Exact Mass: 2974.70
• IUPAC Name: N-[2-(1-cyclopropyl-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(2,8-dimethylquinazolin-4-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-fluoroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[1-(8-methylindolizin-3-yl)ethyl]-1,4-oxazepane-6-carboxamide
• SMILES: CC(C)(NC(=O)C1CNCCOC1)c1ncc2c(F)cccn12.COc1cccn2c(C(C)(C)NC(=O)C3CNCCOC3)ncc12.Cc1cc(F)cn2c(C(C)(C)NC(=O)C3CNCCOC3)ncc12.Cc1cccn2c(C(C)(C)NC(=O)C3CNCCOC3)nc(C)c12.Cc1cccn2c(C(C)(C)NC(=O)C3CNCCOC3)nc(C3CC3)c12.Cc1cccn2c(C(C)NC(=O)C3CNCCOC3)ccc12.Cc1cccn2c(C3(NC(=O)C4CNCCOC4)CCC3)ncc12.Cc1cccn2c(C3(NC(=O)[C@@H]4CNCCO4)CCOC3)ncc12.Cc1nc(C(C)(C)NC(=O)C2CNCCOC2)c2cccc(C)c2n1
• InChI: InChI=1S/C20H28N4O2.C19H26N4O2.C18H24N4O2.C18H26N4O2.C17H23FN4O2.C17H22N4O3.C17H24N4O3.C17H23N3O2.C16H21FN4O2/c1-13-5-4-9-24-17(13)16(14-6-7-14)22-19(24)20(2,3)23-18(25)15-11-21-8-10-26-12-15;1-12-6-5-7-15-16(12)21-13(2)22-17(15)19(3,4)23-18(24)14-10-20-8-9-25-11-14;1-13-4-2-8-22-15(13)11-20-17(22)18(5-3-6-18)21-16(23)14-10-19-7-9-24-12-14;1-12-6-5-8-22-15(12)13(2)20-17(22)18(3,4)21-16(23)14-10-19-7-9-24-11-14;1-11-6-13(18)9-22-14(11)8-20-16(22)17(2,3)21-15(23)12-7-19-4-5-24-10-12;1-12-3-2-6-21-13(12)9-19-16(21)17(4-7-23-11-17)20-15(22)14-10-18-5-8-24-14;1-17(2,20-15(22)12-9-18-6-8-24-11-12)16-19-10-13-14(23-3)5-4-7-21(13)16;1-12-4-3-8-20-15(12)5-6-16(20)13(2)19-17(21)14-10-18-7-9-22-11-14;1-16(2,20-14(22)11-8-18-5-7-23-10-11)15-19-9-13-12(17)4-3-6-21(13)15/h4-5,9,14-15,21H,6-8,10-12H2,1-3H3,(H,23,25);5-7,14,20H,8-11H2,1-4H3,(H,23,24);2,4,8,11,14,19H,3,5-7,9-10,12H2,1H3,(H,21,23);5-6,8,14,19H,7,9-11H2,1-4H3,(H,21,23);6,8-9,12,19H,4-5,7,10H2,1-3H3,(H,21,23);2-3,6,9,14,18H,4-5,7-8,10-11H2,1H3,(H,20,22);4-5,7,10,12,18H,6,8-9,11H2,1-3H3,(H,20,22);3-6,8,13-14,18H,7,9-11H2,1-2H3,(H,19,21);3-4,6,9,11,18H,5,7-8,10H2,1-2H3,(H,20,22)/t;;;;;14-,17?;;;/m.....0.../s1
• InChIKey: ZXSBOGGHNAPHRK-IFWJMMALSA-N
• XLogP: 12.24
• TPSA: 622.99 Ų
• H-Bond Donors: 18
• H-Bond Acceptors: 46
• Rotatable Bonds: 29
• Heavy Atoms: 216
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2976.71
LogP ≤ 5	12.24
H-Bond Donors ≤ 5	18
H-Bond Acceptors ≤ 10	46

Frequently Asked Questions

What is the IUPAC name of N-[2-(1-cyclopropyl-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(2,8-dimethylquinazolin-4-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-fluoroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[1-(8-methylindolizin-3-yl)ethyl]-1,4-oxazepane-6-carboxamide?

The IUPAC name of N-[2-(1-cyclopropyl-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(2,8-dimethylquinazolin-4-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-fluoroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[1-(8-methylindolizin-3-yl)ethyl]-1,4-oxazepane-6-carboxamide (CID 162248853) is N-[2-(1-cyclopropyl-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(2,8-dimethylquinazolin-4-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-fluoroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[1-(8-methylindolizin-3-yl)ethyl]-1,4-oxazepane-6-carboxamide.

What is the SMILES notation for N-[2-(1-cyclopropyl-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(2,8-dimethylquinazolin-4-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-fluoroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[1-(8-methylindolizin-3-yl)ethyl]-1,4-oxazepane-6-carboxamide?

The canonical SMILES for N-[2-(1-cyclopropyl-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(2,8-dimethylquinazolin-4-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-fluoroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[1-(8-methylindolizin-3-yl)ethyl]-1,4-oxazepane-6-carboxamide is CC(C)(NC(=O)C1CNCCOC1)c1ncc2c(F)cccn12.COc1cccn2c(C(C)(C)NC(=O)C3CNCCOC3)ncc12.Cc1cc(F)cn2c(C(C)(C)NC(=O)C3CNCCOC3)ncc12.Cc1cccn2c(C(C)(C)NC(=O)C3CNCCOC3)nc(C)c12.Cc1cccn2c(C(C)(C)NC(=O)C3CNCCOC3)nc(C3CC3)c12.Cc1cccn2c(C(C)NC(=O)C3CNCCOC3)ccc12.Cc1cccn2c(C3(NC(=O)C4CNCCOC4)CCC3)ncc12.Cc1cccn2c(C3(NC(=O)[C@@H]4CNCCO4)CCOC3)ncc12.Cc1nc(C(C)(C)NC(=O)C2CNCCOC2)c2cccc(C)c2n1.

What is the InChIKey of N-[2-(1-cyclopropyl-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(2,8-dimethylquinazolin-4-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-fluoroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[1-(8-methylindolizin-3-yl)ethyl]-1,4-oxazepane-6-carboxamide?

The InChIKey is ZXSBOGGHNAPHRK-IFWJMMALSA-N. The full InChI is InChI=1S/C20H28N4O2.C19H26N4O2.C18H24N4O2.C18H26N4O2.C17H23FN4O2.C17H22N4O3.C17H24N4O3.C17H23N3O2.C16H21FN4O2/c1-13-5-4-9-24-17(13)16(14-6-7-14)22-19(24)20(2,3)23-18(25)15-11-21-8-10-26-12-15;1-12-6-5-7-15-16(12)21-13(2)22-17(15)19(3,4)23-18(24)14-10-20-8-9-25-11-14;1-13-4-2-8-22-15(13)11-20-17(22)18(5-3-6-18)21-16(23)14-10-19-7-9-24-12-14;1-12-6-5-8-22-15(12)13(2)20-17(22)18(3,4)21-16(23)14-10-19-7-9-24-11-14;1-11-6-13(18)9-22-14(11)8-20-16(22)17(2,3)21-15(23)12-7-19-4-5-24-10-12;1-12-3-2-6-21-13(12)9-19-16(21)17(4-7-23-11-17)20-15(22)14-10-18-5-8-24-14;1-17(2,20-15(22)12-9-18-6-8-24-11-12)16-19-10-13-14(23-3)5-4-7-21(13)16;1-12-4-3-8-20-15(12)5-6-16(20)13(2)19-17(21)14-10-18-7-9-22-11-14;1-16(2,20-14(22)11-8-18-5-7-23-10-11)15-19-9-13-12(17)4-3-6-21(13)15/h4-5,9,14-15,21H,6-8,10-12H2,1-3H3,(H,23,25);5-7,14,20H,8-11H2,1-4H3,(H,23,24);2,4,8,11,14,19H,3,5-7,9-10,12H2,1H3,(H,21,23);5-6,8,14,19H,7,9-11H2,1-4H3,(H,21,23);6,8-9,12,19H,4-5,7,10H2,1-3H3,(H,21,23);2-3,6,9,14,18H,4-5,7-8,10-11H2,1H3,(H,20,22);4-5,7,10,12,18H,6,8-9,11H2,1-3H3,(H,20,22);3-6,8,13-14,18H,7,9-11H2,1-2H3,(H,19,21);3-4,6,9,11,18H,5,7-8,10H2,1-2H3,(H,20,22)/t;;;;;14-,17?;;;/m.....0.../s1.

What are the key properties of N-[2-(1-cyclopropyl-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(2,8-dimethylquinazolin-4-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-fluoroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[1-(8-methylindolizin-3-yl)ethyl]-1,4-oxazepane-6-carboxamide?

N-[2-(1-cyclopropyl-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(2,8-dimethylquinazolin-4-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-fluoroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[1-(8-methylindolizin-3-yl)ethyl]-1,4-oxazepane-6-carboxamide has a molecular weight of 2976.71 g/mol, XLogP of 12.24, 29 rotatable bonds, 18 hydrogen bond donors, and 46 hydrogen bond acceptors.

Where does this data come from?

All data for N-[2-(1-cyclopropyl-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(2,8-dimethylquinazolin-4-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-fluoroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[1-(8-methylindolizin-3-yl)ethyl]-1,4-oxazepane-6-carboxamide is sourced from PubChem (CID 162248853), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).